AG-348 (Mitapivat), an allosteric activator of red blood cell pyruvate kinase, increases enzymatic activity, protein stability, and ATP levels over a broad range of PKLR genotypesMinke A.E. Rab, Richard van Wijk, Kendall Johnson et al.|Haematologica|2020Cited by 81
Decreased activity and stability of pyruvate kinase in sickle cell disease: a novel target for mitapivat therapyMinke A.E. Rab, Richard van Wijk, Jennifer Bos et al.|Blood|2021Cited by 46